Donald Hayden

Donald Hayden

Algemeen Directeur bij
WindMIL Therapeutics, Inc.
70 jaar
Health Technology
Consumer Services
Consumer Non-Durables

Profiel

Donald J.
Hayden
is currently the Chairman & Chief Executive Officer at WindMIL Therapeutics, Inc. He is also the Chairman at Avanir Pharmaceuticals, Inc. and Otsuka America Pharmaceutical, Inc. Previously, he held various Chairman positions at Azelon Pharmaceuticals, Inc., Gloucester Pharmaceuticals, Inc., Satori Pharmaceuticals, Inc., Alvine Pharmaceuticals, Inc., REGENXBIO, Inc., Vitae Pharmaceuticals LLC, Transave, Inc., Insmed Ltd., Amicus Therapeutics, Inc., Cogentus Pharmaceuticals, Inc., Otsuka America Pharmaceutical, Inc., Nora Therapeutics, Inc., and Dimension Therapeutics, Inc. He was also the Executive VP & President-Americas Region at Bristol Myers Squibb Co. and Vice President & GM-Mead Johnson Laboratories at Mead Johnson Nutrition Co. Additionally, he served as a Senior Advisor at Prospect Venture Partners.
He received his undergraduate degree from Harvard University and his MBA from Indiana University.

Actieve functies van Donald Hayden

BedrijvenFunctieBegin
Algemeen Directeur 25-04-2019
Voorzitter -

Eerdere bekende functies van Donald Hayden

BedrijvenFunctieEinde
THESEUS PHARMACEUTICALS, INC. Directeur/Bestuurslid 14-02-2024
REGENXBIO INC. Voorzitter 01-07-2020
INSMED INCORPORATED Voorzitter 08-11-2018
AMICUS THERAPEUTICS, INC. Voorzitter 08-02-2010
VITAE PHARMACEUTICALS INC Voorzitter 25-10-2016
Ervaring van Donald Hayden in detail bekijken

Opleiding van Donald Hayden

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

80

Eerstegraads connecties

23

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit23

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Health Technology

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Donald Hayden